T. Rowe Price Associates

T. Rowe Price Associates’s Senti Biosciences Holdings SNTI Stock Holding History

T. Rowe Price Associates’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-314,712	Closed	-$1.34M	–	2930
2023 Q3	$1.34M	Sell	314,712 -24,621	-7%	-$169K	﹤0.01%	1658
2023 Q2	$2.12M	Sell	339,333 -7,454	-2%	-$72.7K	﹤0.01%	1454
2023 Q1	$4.09M	Sell	346,787 -8,615	-2%	-$134K	﹤0.01%	1232
2022 Q4	$5.01M	Sell	355,402 -46,146	-11%	-$1.13M	﹤0.01%	1188
2022 Q3	$8.71M	Buy	401,548 +42,589	+12%	+$839K	﹤0.01%	1090
2022 Q2	$7M	Buy	358,959 +348,892	+3,466%	+$28M	﹤0.01%	1379
2022 Q1	$994K	Hold	10,067	–	–	﹤0.01%	2013
2021 Q4	$993K	Sell	10,067 -289,933	-97%	-$28.9M	﹤0.01%	2043
2021 Q3	$29.8M	Hold	300,000	–	–	﹤0.01%	1183
2021 Q2	$29.8M	Buy	+300,000	New	+$29.9M	﹤0.01%	1201

Other funds holding SNTI

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return